Association between physician specialty and uptake of new medical technologies: HPV tests in Florida Medicaid

Journal of General Internal Medicine

Volumn 25, Issue 11, 2010, Pages 1178-1185

  Price, Rebecca Anhang ^a,b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Appropriate use; Cancer screening; Clinical guidelines; Disparities; Technology adoption.

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICAL TECHNOLOGY; PRACTICE GUIDELINE; UNITED STATES; WART VIRUS;

ADULT; CONTINENTAL POPULATION GROUPS; DNA PROBES, HPV; ETHNIC GROUPS; FEMALE; GENERAL PRACTITIONERS; HUMANS; MASS SCREENING; MEDICAID; MEDICALLY UNDERSERVED AREA; MEDICINE; MIDDLE AGED; MINORITY GROUPS; PHYSICIANS, WOMEN; TECHNOLOGY, MEDICAL; UNITED STATES; VAGINAL SMEARS; YOUNG ADULT;

EID: 78650178794     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1415-9     Document Type: Article

References (41)

1. Harrold LR, Field TS, Gurwitz JH. Knowledge, patterns of care, and outcomes of care for generalists and specialists. J Gen Intern Med. 1999;14(8):499-511. (Pubitemid 29406901)
2. De Smet BD, et al. Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisited. J Gen Intern Med. 2006;21(7):694-7. (Pubitemid 43973552)
3. Hirth RA, Fendrick AM, Chernew ME. Specialist and generalist physicians' adoption of antibiotic therapy to eradicate Helicobacter pylori infection. Med Care. 1996;34(12):1199-204. (Pubitemid 126433217)
4. Landon BE, et al. Physician specialization and antiretroviral therapy for HIV. J Gen Intern Med. 2003;18(4):233-41.
5. Rappaport KM, Forrest CB, Holtzman NA. Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists. Health Serv Res. 2004;39(4 Pt 1):927-47. (Pubitemid 38924686)
6. Agency for Healthcare Research and Quality. National Healthcare Disparities Report. 2008 [cited; Available from: http://www.ahrq.gov/ qual/nhdr08/nhdr08.pdf. Accessed May 2010.
7. Jha AK, et al. Racial trends in the use of major procedures among the elderly. N Engl J Med. 2005;353(7):683-91. (Pubitemid 41175676)
8. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, D.C.; 2003.
9. Epstein AM, et al. Racial disparities in access to renal transplantationclinically appropriate or due to underuse or overuse? N Engl J Med. 2000;343(21):1537-44. 2 p preceding 1537.
10. Schneider EC, et al. Racial differences in cardiac revascularization rates: does "overuse" explain higher rates among white patients? Ann Intern Med. 2001;135(5):328-37. (Pubitemid 32825496)
11. Canto JG, et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med. 2000;342(15):1094-100. (Pubitemid 30207693)
12. Epstein AM, Ayanian JZ. Racial disparities in medical care. N Engl J Med. 2001;344(19):1471-3.
13. Sirovich BE, Welch HG. The frequency of Pap smear screening in the United States. J Gen Intern Med. 2004;19(3):243-50. (Pubitemid 38388934)
14. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. US Department of Health and Human Services: Atlanta, GA; 2004.
15. National Council on Quality Assurance. The State of Health Care Quality. Washington, DC; 2006.
16. Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996- 2000. Cancer. 2007;109(2 Suppl):348-58. (Pubitemid 46106219)
17. Hewitt M, Devesa SS, Breen N. Cervical cancer screening among US women: analyses of the 2000 National Health Interview Survey. Prev Med. 2004;39(2):270-8. (Pubitemid 38834016)
18. Lewis BG, et al. Preventive services use among women seen by gynecologists, general medical physicians, or both. Obstet Gynecol. 2008;111(4):945-52. (Pubitemid 351482628)
19. US Food and Drug Administration. Approval order for Digene Hybrid Capture® 2 (HC2)High-Risk HPV DNA Test - P890064/S009 2003 [cited July 13, 2006]; Available from: http://www.fda.gov/cdrh/pdf/ p890064s009a.pdf. Accessed May 2010
20. Wright TC Jr, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103(2):304-9.
21. US Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Washington: US Department of Health and Human Services; 2003
22. Wright TC Jr, et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287 (16):2120-9. (Pubitemid 34437347)
23. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol. 2003;102 (2):417-27.
24. Saslow D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52 (6):342-62. (Pubitemid 35446606)
25. Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst. 2008;100(5):308-20. (Pubitemid 351480523)
26. Freeman, H., Wingrove, B. Excess cervical cancer mortality: A marker for low access to health care in poor communities. May 2005, National Cancer Institute, Center to Reduce Cancer Health Disparities: Rockville, MD.
27. Saraiya M, et al. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007;109(2 Pt 1):360-70.
28. Centers for Disease Control and Prevention National Center for Health Statistics and Centers for Medicare & Medicaid Services. Conversion Table of New ICD-9-CM Codes. October 2009 [cited; Available from: http://www.cdc.gov/ nchs/data/icd9/icdcnv10.pdf. Accessed May 2010.
29. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol, 2003. 188(6): p. 1383-92.
30. Fitzmaurice, G., Laird, N., Ware, J. Applied Longitudinal Analysis.Wiley Series in Probability and Statistics. 2004, Hoboken, NJ: JohnWiley & Sons.
31. Williams R. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645-646. (Pubitemid 30422662)
32. Irwin K, et al. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States. Obstet Gynecol. 2006;108(2):397-409. (Pubitemid 44305683)
33. Saraiya M, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer. 2007;110(5):1024-32. (Pubitemid 47312868)
34. Noller KL, et al. Cervical cytology screening practices among obstetrician- gynecologists. Obstet Gynecol. 2003;102(2):259-65. (Pubitemid 36936996)
35. Jain N, et al. Use of DNA tests for human Papillomavirus infection by US clinicians, 2004. J Infect Dis. 2007;196(1):76-81. (Pubitemid 46982740)
36. Institute of Medicine. Chapter 2. Definitions and key terms, in Clinical practice guidelines: directions for a new program. In: L.K. Field MJ, Editor. 1990, National Academy Press: Washington, DC.
37. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997;157(4):408-16. (Pubitemid 27384745)
38. Cabana MD, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458-65. (Pubitemid 29493800)
39. Feder G, et al. Clinical guidelines: using clinical guidelines. BMJ. 1999;318(7185):728-30. (Pubitemid 29192002)
40. Grimshaw J, et al. Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998. J Gen Intern Med. 2006;21(Suppl 2):S14-20.
41. O'Malley AS, Pham HH, Reschovsky JD. Predictors of the growing influence of clinical practice guidelines. J Gen Intern Med. 2007;22 (6):742-8. (Pubitemid 46763964)